In the liver, ATGL-mediated lipolysis plays an important function in hepatic lipid homeostasis and ATGL inhibitor, atglistatin substantially reduced high-fat diet-induced hepatosteatosis, obesity, liver inflammation and hepatic fibrosis [1]. The gene discussed is PNPLA2; the disease is obesity due to melanocortin 4 receptor deficiency.